Endocrine dependence of prostatic cancer upon dihydrotestosterone and not upon testosterone

Authors:

Abstract
Growth of the Dunning R3327−H prostatic adenocarcinoma, implanted in the rat, is inhibited by 6−methylene progesterone. This compound is a potent inhibitor of rat prostatic 5-α-reductase and in-vivo produces marked involution of the prostate. Thus the tumor requires dihydrotestosterone and not testosterone for growth.

This publication has 18 references indexed in Scilit: